1. Less Is More and Don’t Eat Me! (#ASCO18)

    This post is one in a series of news updates from ASCO. Read more by clicking here and here. The American Society of Clinical Oncology (#ASCO18) annual meeting is an opportunity to show the progress on investigational cancer therapies, better ways to use old medicines and improved methods of diagnosis. One of the interesting themes to emerge over the past few days here in Chicago is the goal of giving less rather than more treatment. The quest to de-escalate treatment helps avoid bo...

    Read More
  1. Precision Medicine: Hope and Hype #ASCO18

    Using genomics – analyzing a cancer patient’s genetic profile to identify what is causing the malignancy and then using a drug that will work best for that patient’s subtype of cancer – has been evolving over at least two decades. The approach has accelerated in recent years as the technology has improved. And with it there have been stunning successes along with some disappointments. On Saturday at the American Society of Clinical Oncology meeting (#ASCO18) in Chicago, resu...

    Read More
  2. More Progress in Cancer Research at #ASCO18

    Chicago is once again the site of the annual American Society of Clinical Oncology Meeting (#ASCO18), where more than 30,000 scientists, advocates and representatives from the biopharmaceutical industry have gathered to share the their latest clinical findings and to learn from each other in education sessions, scientific presentations and opportunities for networking. The meeting began Friday and continues through Tuesday. The field of cancer science is moving so rapidly and it’s ex...

    Read More
  3. June Calendar of Events!

    Living well with CLL: diagnosis, treatments and support. June 7, 2018 – Valley View, OH Survivorship Program: Staying Healthy Through Nutrition & Exercise June 13, 2018 - White Plains, NY https://www.eiseverywhere.com/336124 Precision Medicine in Myeloma Treatment June 14, 2018 - Boca Raton, FL https://www.eiseverywhere.com/335839 Moving Forward: Updates on Leukemia, Lymphoma, and CAR T-Cell Immunotherapy June 19, 2018 - San Francisco, CA www.bit.ly/llsmovingforward ...

    Read More
  1. Why You Can’t Get Consistent Answers to Your Nutrition Questions

    Written by Cathy Leman, MA, RD, LD After a cancer diagnosis, many people have questions about the role nutrition can play in their cancer journey. There is so much nutrition information available online, but not all this information is reliable. Hear from registered dietitian and breast cancer survivor Cathy Leman, MA, RD, LD about why it’s so hard to find consistent answers to your nutrition questions. Last weekend I had the sincere pleasure of attending my first oncology nutrition...

    Read More
  2. Podcast Episode: Motherhood and Survivorship

    Mother's Day is a celebration honoring mothers, motherhood, maternal bonds, and the influence of mothers in society. In this episode, Alicia and Lizette speak with survivor Katy Ursta, a mother of two adorable young boys. Katy speaks about her diagnosis of Hodgkin lymphoma at age 30, and how she and her husband worked to keep the their young family going, while maintaining normalcy around both their four year old and four months old sons. She speaks about the importance of support, having ...

    Read More
  3. Supplemental Nutrition Assistance Program (SNAP)

    A cancer diagnosis can put a financial strain on patients, caregivers, and their families. Even with health insurance, the cost of treatment can be difficult to manage. If the patient stops working because of treatment or the caregiver stops working to provide care, the loss of income makes it even more difficult to make ends meet. In these situations, the budget left for healthy foods may be minimal. The Supplemental Nutrition Assistance Program (SNAP), formerly known as food stamps, provide...

    Read More
  4. More Progress on LLS-Supported CAR T-cell Immunotherapy

    Rye Brook, N.Y. (May 2, 2018) – The latest approval of a game-changing personalized cancer therapy on Tuesday is further proof of the promise of immunotherapy, an approach that The Leukemia & Lymphoma Society (LLS) supported early on and which holds great promise for blood cancer patients, as well as for patients with other types of cancers. The U.S. Food and Drug Administration (FDA) granted tisagenlecleucel (Kymriah®) its second approval to treat patients with diffuse large B-c...

    Read More
  5. May Calendar of Events

    Happy May! Here is a list of our upcoming May events for patients and caregivers, free of charge. Take a look to see if we are coming to you! New and Emerging Therapies: Non-Hodgkin Lymphoma May 8, 2018 - Anaheim, CA http://bit.ly/May8NHL Meet the treatment Team: A Conversation about Blood Cancers May 8, 2018 - Athens, GA https://www.eiseverywhere.com/326803 Navigating the Path: A Patient’s Journey May 10, 2018 - Bay Shore, NY https://www.eiseverywhere.com/331384 6th Annua...

    Read More
  6. Game-Changing Cancer Progress Presented at AACR

    More than 20,000 cancer scientists from around the globe came to Chicago this week to share and learn about the latest advances in research and treatments at the annual meeting of the American Association of Cancer Research (AACR). AACR is one of the world’s oldest and largest nonprofits dedicated to cancer research and education. Blood cancers were among the thousands of scientific presentations and educational sessions. And while much of the excitement focused on lung cancer and ot...

    Read More